Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
about
Current Concepts in Multiple Sclerosis: Autoimmunity Versus OligodendrogliopathyEffects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and UveitisThe biological functions of T helper 17 cell effector cytokines in inflammationThe T-cell pool is anergized in patients with multiple sclerosis in remissionThe differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammatImpact of Exercise on Innate Immunity in Multiple Sclerosis Progression and SymptomatologyTh17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic ImplicationsAdvances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple SclerosisCD8(+) T-Cells as Immune Regulators of Multiple SclerosisInvolvement of CD8(+) T Cells in Multiple SclerosisThe Non-Obese Diabetic Mouse Strain as a Model to Study CD8(+) T Cell Function in Relapsing and Progressive Multiple SclerosisThe immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS)Change of paradigm: CD8+ T cells as important helper for CD4+ T cells during asthma and autoimmune encephalomyelitisA role for Th17 cells in the regulation of tertiary lymphoid folliclesStage-specific immune dysregulation in multiple sclerosisRegulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological DisordersDiversity of IL-17-producing T lymphocytesRole of CD8 T cell subsets in the pathogenesis of multiple sclerosisMultiple sclerosis: the role of cytokines in pathogenesis and in therapiesSphingosine-1-phosphate receptor 1 signalling in T cells: trafficking and beyondImmune Components of Liver Damage Associated with Connective Tissue DiseasesFingolimod for the treatment of neurological diseases-state of play and future perspectivesIs Multiple Sclerosis an Autoimmune Disease?Immunomodulatory Effects Mediated by DopamineNF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic ImplicationsEnvironmental factors in autoimmune diseases and their role in multiple sclerosisNo quiet surrender: molecular guardians in multiple sclerosis brainMultiple Sclerosis and T Lymphocytes: An Entangled StoryPlasma biomarkers discriminate clinical forms of multiple sclerosisAstrocytes in multiple sclerosis: a product of their environmentThe IL-17 pathway as a major therapeutic target in autoimmune diseasesAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitisAmelioration of experimental autoimmune encephalomyelitis by anatabineMicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosisAn approach to control relapse of inflammatory lesions after discontinuation of primary therapyNeuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammationMicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitisDifferential Frequency of CD8+ T Cell Subsets in Multiple Sclerosis Patients with Various Clinical PatternsCirculating immune cells in multiple sclerosis.
P2860
Q22252578-C896222D-3292-4BC6-9D97-4A28EBDBE43AQ22299388-9CF56990-67E1-43B6-B0E0-CA5EEB02BC2FQ24614431-B8EBC29F-5FB2-498B-99D2-8ECC798E5CAAQ24643433-DC7F2878-726B-4302-8AD7-F2589F677837Q24648890-0E33576F-B758-422A-B707-DE2B1B0B7286Q26745562-9D01B571-8A96-475C-9B49-115BB1999EE0Q26768649-A1066C81-683B-4FEC-A258-3031C914C6AFQ26771957-B02E1AF5-6419-4F48-BF61-CB2053A2C533Q26772339-7F811B69-CEAF-46C8-BE86-A94EAF236537Q26774642-47094201-92FB-49F8-B088-F3C306B3D87EQ26777944-B44D4C98-FAE4-4251-98A4-D6C88E085285Q26823691-F5FB704D-E218-4641-A032-88E85B584E68Q26824572-8C922EB8-CCB1-4469-91E7-493AD850F38BQ26851559-B17856C6-B639-4E40-82E7-24B8F39A65FCQ26852859-3587BDAE-B6ED-4F35-9A6C-E8EF3BB20701Q26997105-BFDCD72A-E5AD-446F-A275-1145E1493A78Q27010199-862D86A6-9357-4EC8-B0AC-E1C0748FA6EBQ27010613-120D72C2-CA7A-4DB7-8ABD-7B40649190D4Q27011014-06D4CB5C-12B8-464F-BC7C-CE434D4786E7Q27011857-FA88CC2F-3698-4098-8928-218F77444707Q27015533-56375B71-9CF8-4318-A348-CB6C05C9B56DQ27026175-85C74BC8-9A64-413B-ADA2-3A386B9D4983Q27496011-F341D394-7E07-44C7-BBA6-879F137BAFE2Q28071580-6132777C-2E2A-4E3B-AB3D-6636033B942BQ28078299-CA22A5C2-B1DE-4459-A0C8-5D1CF29B29D9Q28078461-12D0EAF0-2844-4952-ADFB-908BE1A3AA44Q28084633-461D10ED-4B9F-4912-991C-083FA60E988BQ28086853-632229AF-A5FB-4B37-AF4A-5E6780C01F1DQ28262774-08450F0B-853B-4F9F-927B-B63103997151Q28282324-4491BE42-509A-4D0A-8CCE-743240F0899DQ28300826-91C8894E-2490-4255-8A5A-C779255DCFEEQ28395248-60A01B38-9857-47CE-A98E-271678473CE6Q28475567-3B6A95B6-F2F0-4E7D-A008-F87878D8E482Q28485371-1977B426-973D-456A-AE0F-4CEC86711AD8Q28509195-24192815-8044-4058-A01A-A684FB632A90Q28538993-7EAF7757-D672-433C-AF32-324DCE184F84Q28565232-AE3AB039-4625-439C-BF18-B3E044F034FAQ28975627-7A353D04-67A5-465C-8175-54C1244D18FBQ29391765-5522726D-F1A1-493A-8525-92FEA11F519BQ30242026-D7499C25-0BEA-432C-95C1-75D14D90EC98
P2860
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interleukin-17 production in c ...... disease in multiple sclerosis
@ast
Interleukin-17 production in c ...... disease in multiple sclerosis
@en
Interleukin-17 production in c ...... disease in multiple sclerosis
@nl
type
label
Interleukin-17 production in c ...... disease in multiple sclerosis
@ast
Interleukin-17 production in c ...... disease in multiple sclerosis
@en
Interleukin-17 production in c ...... disease in multiple sclerosis
@nl
prefLabel
Interleukin-17 production in c ...... disease in multiple sclerosis
@ast
Interleukin-17 production in c ...... disease in multiple sclerosis
@en
Interleukin-17 production in c ...... disease in multiple sclerosis
@nl
P2093
P2860
P3181
P1476
Interleukin-17 production in c ...... disease in multiple sclerosis
@en
P2093
Jackie Palace
Jia Newcombe
John S Tzartos
Margaret M Esiri
Matthew J Craner
P2860
P304
P3181
P356
10.2353/AJPATH.2008.070690
P407
P577
2008-01-01T00:00:00Z